Meiwu Technology Co Ltd Announces $14 Million Registered Direct Offering

Rhea-AI Summary

Meiwu Technology (NASDAQ: WNW) announced a registered direct offering to sell 6,999,996 ordinary shares at $2.00 per share and issue warrants to purchase up to 6,999,996 shares at an exercise price of $2.00. The warrants have a 1-year term.

The aggregate gross proceeds are expected to be approximately $14 million. The offering is expected to close on or about March 18, 2026, subject to customary closing conditions, with Univest Securities acting as sole placement agent.

Positive

• Gross proceeds of approximately $14 million
• Immediate capital through sale of 6,999,996 shares at $2.00
• Paired warrants provide potential additional capital if exercised at $2.00

Negative

• Issuance of 6,999,996 shares will dilute existing shareholders' ownership
• Warrants exercisable into 6,999,996 shares could cause further dilution if exercised
• Short 1-year warrant term concentrates potential dilution into a near-term period

News Market Reaction – WNW

-79.97% 14.3x vol

64 alerts

-79.97% News Effect

+18.1% Peak Tracked

-82.7% Trough Tracked

-$460M Valuation Impact

$115M Market Cap

14.3x Rel. Volume

On the day this news was published, WNW declined 79.97%, reflecting a significant negative market reaction. Argus tracked a peak move of +18.1% during that session. Argus tracked a trough of -82.7% from its starting point during tracking. Our momentum scanner triggered 64 alerts that day, indicating high trading interest and price volatility. This price movement removed approximately $460M from the company's valuation, bringing the market cap to $115M at that time. Trading volume was exceptionally heavy at 14.3x the daily average, suggesting significant selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Ordinary shares offered: 6,999,996 shares Offering price: $2.00 per share Investor warrants: 6,999,996 shares +5 more

8 metrics

Ordinary shares offered 6,999,996 shares Registered direct offering

Offering price $2.00 per share Registered direct offering purchase price

Investor warrants 6,999,996 shares Warrants to purchase ordinary shares

Warrant exercise price $2.00 per share Exercise price for investor warrants

Warrant term 1 year Term from date of issuance

Gross proceeds $14 million Expected aggregate gross proceeds from offering

Form F-3 file number File No. 333-292111 Shelf registration statement reference

Shelf effective date February 24, 2026 Date Form F-3 became effective per article

Market Reality Check

Price: $0.2001 Vol: Volume 174,362,231 is abo...

high vol

$0.2001 Last Close

Volume Volume 174,362,231 is about 19.58x the 20-day average of 8,906,263 shares, indicating unusually heavy trading before this offering. high

Technical Trading above the 200-day moving average at $1.70, with a pre-news price of $2.15.

Peers on Argus

Momentum scanner shows 2 peers (including IPW and MI) moving down around -3.19% ...

1 Up 2 Down

Momentum scanner shows 2 peers (including IPW and MI) moving down around -3.19% and -2.93%, with one peer (JFBR) up about 7.75%. Scanner flags this as part of a broader sector move.

Historical Context

1 past event · Latest: Mar 16 (Positive)

Pattern 1 events

Date	Event	Sentiment	Move	Catalyst
Mar 16	AI strategy update	Positive	+625.3%	Announced AI insights initiative to support functional skincare R&D and workflows.

Pattern Detected

The only recent event shows a very strong positive price reaction to strategic news, indicating sensitivity to corporate announcements.

Recent Company History

In the past months, Meiwu Technology reported an AI insights initiative to support functional skincare R&D on 2026-03-16, aimed at improving formulation analysis and research coordination. That announcement saw a strong +625.28% 24-hour reaction, suggesting the stock had already moved sharply on strategic news before this financing. Today’s registered direct offering adds a capital-raising step following that momentum-driven period.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2026-02-23

The company has an active Form F-3/A shelf dated 2026-02-23, allowing offerings from time to time after effectiveness, with amendment No. 3 mainly updating Exhibit 23.1 and the exhibit index while keeping the prior prospectus terms unchanged.

Market Pulse Summary

The stock dropped -80.0% in the session following this news. A negative reaction despite recent stro...

Analysis

The stock dropped -80.0% in the session following this news. A negative reaction despite recent strong momentum would fit a pattern where investors reassess dilution risk. The company is issuing 6,999,996 shares and the same number of warrants at $2.00, targeting about $14 million in gross proceeds under its shelf. After a prior AI-related announcement saw a +625.28% move, some holders could lock in gains as new supply arrives, and future use of the Form F-3/A program may remain a consideration.

Key Terms

registered direct offering, warrants, shelf registration statement, form f-3, +1 more

5 terms

registered direct offering financial

"at a purchase price of $2.00 per share in a registered direct offering."

A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.

warrants financial

"The Company also agreed to issue to the same investors warrants (the "Warrants") to purchase"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

shelf registration statement regulatory

"pursuant to a shelf registration statement on Form F-3 (File No. 333-292111)"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form f-3 regulatory

"pursuant to a shelf registration statement on Form F-3 (File No. 333-292111)"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

prospectus supplement regulatory

"A final prospectus supplement and accompanying prospectus describing the terms"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. Not financial advice.

SHENZHEN, China, March 17, 2026 /PRNewswire/ -- Meiwu Technology Co Ltd (NASDAQ: WNW) (the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 6,999,996 of the Company's ordinary shares, no par value each (the "Shares") at a purchase price of $2.00 per share in a registered direct offering.

The Company also agreed to issue to the same investors warrants (the "Warrants") to purchase up to 6,999,996 ordinary shares at an exercise price of $2.00 per share. The Warrants will have a 1-year term from the date of issuance.

The aggregate gross proceeds to the Company of this offering are expected to be approximately $14 million. The transaction is expected to close on or about March 18, 2026, subject to the satisfaction of customary closing conditions.

Univest Securities, LLC is acting as the sole placement agent.

The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-292111) previously filed by the Company with the U.S. Securities and Exchange Commission ("SEC") and became effective on February 24, 2026. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC's website at www.sec.gov.

About Meiwu Technology Co Ltd

Meiwu Technology Company Limited is a British Virgin Islands company incorporated on December 4, 2018. Meiwu implemented a strategic transition of its business from online sales of selected high-quality food products and short message service to the skincare industry, and currently engages in the sale of the functional skincare products through Xiamen Chunshang Health Technology Co., Ltd. ("Chunshang Xiamen"), an indirect wholly owned subsidiary of Meiwu in China.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission.

Meiwu Technology Co Ltd

Zhichao Yang
Email: meiwuBS@usmeiwu.com 

View original content:https://www.prnewswire.com/news-releases/meiwu-technology-co-ltd-announces-14-million-registered-direct-offering-302716048.html

SOURCE Meiwu Technology Co Ltd

FAQ

What are the key terms of Meiwu Technology's (WNW) March 17, 2026 offering?

The offering sells 6,999,996 shares at $2.00 and issues warrants for the same number of shares. According to the company, aggregate gross proceeds are expected to be approximately $14 million and the warrants have a 1-year term.

When is the Meiwu Technology (WNW) registered direct offering expected to close?

The transaction is expected to close on or about March 18, 2026, subject to customary closing conditions. According to the company, closing depends on satisfaction of those customary conditions and filings.

How many warrants did Meiwu Technology (WNW) issue and what is the exercise price?

Meiwu will issue warrants to purchase up to 6,999,996 shares at an exercise price of $2.00. According to the company, the warrants have a 1-year exercise period from issuance.

How much capital will Meiwu Technology (WNW) raise from the registered direct offering?

The company expects to raise approximately $14 million in gross proceeds from the offering. According to the company, this figure reflects sale of shares at $2.00 each before expenses and any warrant exercises.

Who is acting as placement agent for Meiwu Technology's (WNW) offering and where is the filing available?

Univest Securities, LLC is the sole placement agent for the transaction. According to the company, the final prospectus supplement and prospectus will be filed with the SEC and available on www.sec.gov.